Floatz logo

Therapeutic Asset Ratings

134 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Sitravatinib
Breast Neoplasm
Xiang ZhangP2CC (46)
Fludarabine
Breast Neoplasm
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityP1/2CC (46)
Tumor-Draining Lymph Node-Derived Lymphocyte
Breast Neoplasm
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityP1/2CC (46)
Immunoglobulin G1, anti-(human neuregulin receptor HER3) (human monoclonal U3-1287 heavy chain), disulfide with human monoclonal U3-1287 ?-chain, dimer
Breast Neoplasm
QuantumLeap Healthcare CollaborativeP2CC (44)
[18f]f-resca-rb14
Breast Neoplasm
RenJi HospitalP1/2CC (41)
[18f]f-resca-rt4
Breast Neoplasm
RenJi HospitalP1/2CC (41)
Ibrutinib
Breast Neoplasm
US Oncology ResearchP1/2CC (41)
LENVATINIB
Breast Neoplasm
Zhejiang Cancer HospitalP1/2CC (41)
Tislelizumab
Breast Neoplasms
BriaCell Therapeutics CorporationP1/2CC (41)
Zelenectide Pevedotin
Breast Neoplasm
BicycleTx LimitedP1/2CC (41)
Ganciclovir
Breast Neoplasm
Gene Surgery LLCP1CC (40)
Herclon
Breast Neoplasm
Incepta Pharmaceuticals LtdP1CC (40)
Stimotimagene Copolymerplasmid
Breast Neoplasm
Gene Surgery LLCP1CC (40)
Amcenestrant
Breast Neoplasm
QuantumLeap Healthcare CollaborativeP2C (39)
[68ga]ga-dwj155
Breast Neoplasm
Novartis PharmaceuticalsP1C (37)
allogeneic natural killer (NK) cells isolated from peripheral blood leukapheresis of individual donors. The cells are co-cultured in media containing interleukin 15 (IL-15) and nicotinamide (NAM, niacinamide) with expansion enhanced by the presence of feeder cells. The final cell population consists of 97-99% CD3-CD56+ NK cells, with >10% expressing CD16 (also known as Fc?RIII) and CD62L (also known as L-selectin) and with capacity to degranulate (surface expression of CD107? [Lysosome-associated membrane glycoprotein 1]; >10%), and to kill target cells (>10%) in co-culture assays against human cancer cell lines.
Breast Neoplasm
Vall d'Hebron Institute of OncologyP1C (37)
Atv-1601
Breast Neoplasm
Atavistik Bio, IncP1C (37)
Cid-078 Monotherapy
Breast Neoplasm
Circle PharmaP1C (37)
Codalytic
Breast Neoplasm
Codagenix, IncP1C (37)
dm001
Breast Neoplasm
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.P1C (37)
FGF/FGFR PATHWAY INHIBITOR E7090
Breast Neoplasm
Eisai Co., Ltd.P1C (37)
Loperamide
Breast Neoplasm
Eli Lilly and CompanyP1C (37)
ly3023414
Breast Neoplasm
Eli Lilly and CompanyP1C (37)
ly4257496
Breast Neoplasm
Eli Lilly and CompanyP1C (37)
ly4337713
Breast Neoplasm
Eli Lilly and CompanyP1C (37)
Showing 101 to 125 of 134 assets
PreviousPage 5 of 6Next